NCT07814573

Brief Summary

The purpose of this prospective, randomized controlled clinical trial is to evaluate early postoperative outcomes and fluid drainage dynamics between continuous active negative-pressure chest drainage (-10 mmHg) and standard spontaneous closed underwater-seal drainage in adult patients undergoing elective isolated coronary artery bypass grafting (CABG).

Trial Health

75
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
400

participants targeted

Target at P75+ for not_applicable

Timeline
12mo left

Started Sep 2026

Geographic Reach
1 country

1 active site

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress9%
Sep 2026Sep 2027

Study Start

First participant enrolled

September 1, 2026

Completed
4 days until next milestone

First Submitted

Initial submission to the registry

September 5, 2026

Completed
6 days until next milestone

First Posted

Study publicly available on registry

September 11, 2026

Completed
12 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 31, 2027

Expected
15 days until next milestone

Study Completion

Last participant's last visit for all outcomes

September 15, 2027

Last Updated

September 22, 2026

Status Verified

September 1, 2026

Enrollment Period

12 months

First QC Date

September 5, 2026

Last Update Submit

September 18, 2026

Conditions

Keywords

drainagecabgcoronary artery bypass graftcardiovascular surgerycardiac surgery

Outcome Measures

Primary Outcomes (3)

  • Pre-discharge echocardiographic assessment

    Pericardial effusion volume and left ventricular ejection fraction (LVEF) measured in percentage (%) via transthoracic echocardiography prior to hospital discharge.

    7-14 days after the surgery

  • Cumulative drainage volume at 24 and 48 hours

    Total volume of thoracic drainage fluid measured in milliliters (mL) at 24 and 48 hours postoperatively.

    First 24 and 48 hours after the surgery

  • Incidence of postoperative complications

    Rate of early complications occurring within 48 hours postoperatively, including postoperative atrial fibrillation (POAF), pneumothorax, and symptomatic pleural effusion requiring intervention. Composite rate of major complications within 30 days postoperatively, including surgical re-exploration for bleeding or cardiac tamponade, requirement for extracorporeal membrane oxygenation (ECMO) support, deep sternal wound infection or sternal revision, and 30-day all-cause mortality.

    It will be evaluated during the patient follow-ups at the first 48 hours and the one-month check-ups.

Secondary Outcomes (2)

  • Postoperative recovery metrics

    from surgery to discharge (5-30 days)

  • Duration of intubation

    10-360 hours

Study Arms (2)

No-Negative Pressure Group

NO INTERVENTION

patients not subjected to negative pressure and managed with routine underwater-seal drainage

Negative Pressure Group

ACTIVE COMPARATOR

patients monitored under negative pressure

Procedure: monitoring of drainage using negative pressure

Interventions

Continuous low-intensity active negative-pressure suction (-10mmHg) applied to chest drains via central vacuum wall suction for the first 48 hours postoperatively following coronary artery bypass grafting (CABG).

Negative Pressure Group

Eligibility Criteria

Age18 Years - 80 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients scheduled for elective, isolated coronary artery bypass grafting (CABG) via median sternotomy.
  • Adult patients aged from 18 to 80 years.
  • Patients who provide written informed consent prior to study enrollment.

You may not qualify if:

  • Patients undergoing emergency coronary artery bypass grafting (CABG) or emergency surgical re-exploration.
  • Patients under 18 years or over 80 years of age.
  • Patients undergoing re-do cardiac surgery.
  • Pre-existing pericardial effusion or significant pleural effusion detected on baseline imaging.
  • Pre-existing baseline coagulopathy or active bleeding disorder.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Başakşehir Çam Ve Sakura Şehir Hastanesi

Istanbul, Istanbul, 34480, Turkey (Türkiye)

Location

Study Officials

  • Süleyman Yazıcı, MD, Assoc. Prof.

    BAŞAKŞEHİR ÇAM VE SAKURA ŞEHİR HASTANESİ

    STUDY DIRECTOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER GOV
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Cardiovascular Surgery Resident

Study Record Dates

First Submitted

September 5, 2026

First Posted

September 11, 2026

Study Start

September 1, 2026

Primary Completion (Estimated)

August 31, 2027

Study Completion (Estimated)

September 15, 2027

Last Updated

September 22, 2026

Record last verified: 2026-09

Data Sharing

IPD Sharing
Will not share

Patient data cannot be shared with third parties, as specified during the ethics committee application.

Locations